Stocks Pfizer Inc

More

  • Swine Flu: global pandemic or paranoia? President Obama said the health emergency declaration was merely a prudent measure. But many pharmaceutical stocks were sharply higher Monday in reaction to flu outbreaks — and the gains seemed to ripple through the sector.

  • FFF_Fast_Furious_Thumb.jpg

    Following are the “Fast & Furious” trades - hot ways to play tomorrow's market moving events. Also you'll find the gang's "Final Trades" here.

  • Stocks ended higher Friday after better-than-expected results from Ford but ended lower for the week, snapping a six-week winning streak. recovered Friday after a drop triggered by the release of the bank stress-test results.

  • As stocks capped a seventh consecutive week of gains, traders Marty Cunningham of Solazzo Trading Company and Michael Gurka of First Street Capital Partners considered how much room remains for the rally.

  • pfizer_hq.jpg

    At Pfizer's annual shareholder meeting in Atlanta this morning, investors approved a version of "Say on Pay."

  • CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.

  • dendreon.jpg

    Not a surprise, but my post yesterday on what one reader called the analyst "flip-flop" on Dendreon generated a lot of responses and queries.

  • webxtra_thumb.jpg

    In this Web Extra, Pete Najarian talks Pharma takeovers. What's on his radar?

  • Following are the day’s biggest winners and losers. Find out why shares of Yum! Brands and Piper Jaffray popped while Microsoft and Abbott Labs dropped.

  • Oh, the fun the late-night comics could have with this one. The makers of the little blue pill are a little red-faced on the Emerald Isle.

  • With stocks rallying for 5 weeks in a row now, dividend yields are falling back to Earth.  The average dividend yield of the Dow 30 has fallen over 25% since the rally began in early March.  See how the 30 companies in the Dow compare.

  • BlackRock's Bob Doll says the investor needs to realize where we are in both the economic cycle and the market cycle, and he has some suggestions about where to re-adjust a portfolio. (Part One)

  • BlackRock's Bob Doll says the investor needs to realize where we are in both the economic cycle and the market cycle, and he has some suggestions about where to re-adjust a portfolio. (Part Two)

  • Cramer makes the call on viewers' favorite stocks.

  • A drug from Novartis has won U.S. approval as a treatment for patients with kidney cancer that has returned after treatment with older drugs.

  • At the start of the month, General Electric was falling fast and the company that once boasted a half trillion dollar market cap, was at risk of falling out of the Top 20 biggest companies in the S&P 500.  In less than a month, that has changed significantly.

  • Despite the drawback in stocks this morning, Bill Spiropoulous of CoreStates Capital Advisors told CNBC that the market recovery “is in full swing” — but Joe Heider of Dawson Wealth Management said investors “can’t call the bottom” yet. Both had investment recommendations.

  • webxtra_thumb.jpg

    The Pit Boss is seeing explosive options action in a drug stock. Find out which one!

  • The economy may be headed toward a recovery sometime in the third or fourth quarter, said Hugh Johnson of Johnson Illington Advisors.

  • M&A expert Howard Lanser reveals the next sector where he expects to see a big uptick in takeovers!